Bio X Cell has unveiled a refreshed brand identity, which aims to bridge nearly 30 years of scientific leadership in the functional antibody space with expanding global capabilities across the pre-clinical research workflow.
Since its inception nearly 30 years ago, Bio X Cell has provided functional antibody solutions that empower scientists across cancer, immunology, neuroscience and infectious disease research areas.
It is now a leading producer of monoclonal antibodies (mAbs) for use primarily in preclinical in vivo research applications.
The company also boasts the world's largest production facility dedicated to manufacturing functional antibodies.
With a 2000L monthly throughput capacity, the newly upgraded Bio X Cell manufacturing facility is designed for flexibility to enable custom sizes and formulations tailored for both in vivo animal studies and in vitro-organoids/organs-on-chip studies.
Located in the United States, with expanded global operations in China and Germany and a network of distribution partners, the facility allows for rapid delivery of Bio X Cell solutions to researchers across the world.
Bio X Cell's refreshed look marks the company's deepened commitment to modern research across biopharma, academia and biotech.
As the only life science solutions provider able to support researchers with 100% PhD-level technical support and the only functional antibody company able to claim nearly 30,000 product citations, the refreshed branding, logo and branded typeface represent the evolution of Bio X Cell's place alongside scientific advancement from classic in vivo models to advanced platforms.
Bio X Cell is also expanding its catalogue to include modern antibody solutions such as bispecifics and ADCs, workflow solutions that allow researchers to bridge high-throughput NAM studies with complex in vivo models and custom services which allow scaling and customisation of RUO-grade antibodies from milligrams to grams.
"Building on our heritage as a trusted provider of ultra-pure, functional antibodies, we are expanding our capabilities to meet the needs of cutting-edge research models from advanced NAM platforms and organoids to complex in vivo studies." Christopher Conway, CEO of Bio X Cell.
"Backed by PhD-level expertise, our antibody solutions combine scientific rigour with innovative formulation and scalable capacity, ensuring precise, reproducible and translatable results."
"Our growing global operations and distribution network provide faster, more reliable access to these critical tools, helping scientists accelerate discovery worldwide."
As Bio X Cell enters this new chapter, its refreshed brand identity reflects not just where the company has been, but how the company is embracing expansion, innovation and global reach while continuing to focus on empowering translational research.
Bio X Cell remains the trusted partner for scientists working at the forefront of discovery.
From classic in vivo models to next-generation platforms, Bio X Cell delivers antibody solutions that move science forward.